Literature DB >> 2872650

The immature rat small intestine exhibits an increased sensitivity and response to Escherichia coli heat-stable enterotoxin.

M B Cohen, M S Moyer, M Luttrell, R A Giannella.   

Abstract

Escherichia coli which elaborate heat stable enterotoxin (ST) are a major cause of endemic diarrhea in infants. The reason(s) for this increased susceptibility of infants to ST-mediated diarrhea is unknown. We investigated the possibility that the immature (14 and 21 day old) rat small intestine is more sensitive to ST than is the adult. Initially we found there was a 600-fold increased jejunal sensitivity to ST in the immature animals as measured by dose required for half maximal secretion. Also there was a greater jejunal secretory response in the immature animals (14 greater than or equal to 21 days old greater than adult). To determine the cause for this increased sensitivity and secretory response to ST, we examined: 1) binding characteristics of 125I-ST to brush border membrane (BBM) receptors and 2) membrane bound guanylate cyclase activation by ST in both immature and adult rats. Our findings demonstrate that more ST receptors are present in jejunal BBM from 14- and 21-day-old rats than in jejunal BBM from adult rats (2.34 +/- 0.18, 2.85 +/- 0.82, and 0.79 +/- 0.13 X 10(12) receptors/mg BBM protein, respectively), while the affinity of the BBM receptor for ST is similar at all three ages in both jejunum and ileum. Furthermore, both the jejunum and ileum of the rats of all three ages revealed an equal sensitivity of guanylate cyclase to activation by ST. These findings suggest that the increased number of jejunal receptors in the immature rat may, in part, explain the increased sensitivity and secretory response observed in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872650     DOI: 10.1203/00006450-198606000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

Review 2.  Molecular staging individualizing cancer management.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  J Surg Oncol       Date:  2012-04-01       Impact factor: 3.454

Review 3.  GUCY2C molecular staging personalizes colorectal cancer patient management.

Authors:  Jian P Gong; Stephanie Schulz; Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2012-06       Impact factor: 2.851

4.  Heat stable enterotoxin produced by Escherichia coli in acute diarrhoea.

Authors:  A Guarino; M Alessio; L Tarallo; M Fontana; G Iacono; L Gobio Casali; S Guandalini
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

5.  Age and segmental differences in 5-hydroxytryptamine-induced hypersecretion in the pig small intestine.

Authors:  M L Grøndahl; M B Hansen; I E Larsen; E Skadhauge
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

6.  Age-dependent changes in affinity-labeled receptors for Escherichia coli heat-stable enterotoxin in the swine intestine.

Authors:  L C Katwa; C D Parker; A A White
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

7.  Differential binding kinetics of cholera toxin to intestinal microvillus membrane during development.

Authors:  W I Lencer; S H Chu; W A Walker
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

8.  Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

9.  Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

Authors:  R Eglow; C Pothoulakis; S Itzkowitz; E J Israel; C J O'Keane; D Gong; N Gao; Y L Xu; W A Walker; J T LaMont
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Expert Rev Mol Diagn       Date:  2009-11       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.